Trial Profile
Study of anti-VEGF treatment regimen for macular oedema in retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use